Latest Articles

LDL-C The Only Causal Risk Factor for ASCVD

Why low-density lipoprotein-cholesterol, the only causal risk factor for atherosclerotic cardiovascular disease, is still overlooked and underestimated.

LDL-C Targets in Patients with Heterozygous Familial Hypercholesterolemia

PCSK9 Inhibitors in Real World Practice

iGlarLixi Enables Safe Ramadan Fasting for Most T2D Patients

New 2022 ADA/EASD Guidelines: GLPP-1 RA/Insulin Combination Is Recommended

ADA/EASD recommend considering combination injectables therapy of basal insulin/GLP-1 RA (Such as Soliqua^®) as valuable treatment option to provide adequate efficacy for achieving and maintaining glycemic goals.

Recommendations on treatment simplification of complex insulin regimens to improve clinical outcomes in patients with T2DM

Diabetes management during Ramadan

Closed-loop insulin delivery during exercise in people with T1DM

Post-exercise hypoglycemia in relation to medication regimen among adults with type 2 diabetes